“Creative” FDA Clears Avastin For First-Line Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Accelerated approval wants more clinical proof.
You may also be interested in...
FDA Ties Brisdelle Approval To Unmet Need For Hormone-Free Therapy
In an NEJM perspective piece, agency reviewers explain why they believed Noven’s paroxetine for treating hot flashes should come to market despite only “modest” efficacy and an advisory committee’s overwhelming recommendation against approval.
Avastin Passes Tox Test In Colon Cancer
Drug and control arms in C-08 study of Genentech drug turn out the same.
Avastin Passes Tox Test In Colon Cancer
Drug and control arms in C-08 study of Genentech drug turn out the same.